Please login to the form below
Breath test could predict response to immunotherapy
Study found device accurately predicted responses in lung cancer
Bluebird Bio reveals further encouraging data for CALD gene therapy
Study shows continued benefit in treatment of rare disease
Biogen loses another pipeline drug to toxicity concerns
Follows discontinuation of Eisai-partnered Alzheimer's drug
Novartis eyes potential new indication for Cosentyx
Unveils positive late-stage results in axial spondyloarthritis
Acceleron scraps rare muscular dystrophy drug
Clinical profile not strong enough to push into late-stage testing
New data backs GeNeuro’s MS drug after Servier exit
Search continues for new development partner
Biogen and Eisai drop Alzheimer’s drug elenbecestat
Latest blow in string of failures for BACE inhibitor category
Celgene’s ‘oral Vidaza’ clears phase 3 leukaemia trial
Regulatory filings expected in first half of 2020
Adopting a creative IP approach towards biotech clusters
Why big pharma paradigm needs to change
-
A unique ecosystem How life science and healthcare clusters are driving innovation
-
Riding the wave of digital disruptionThe challenges and rewards of meeting consumer expectations
-
Roche preps filings for Herceptin/Perjeta combinationPotential defence against biosimilar competition
-
IQVIA and partners set up cancer ‘data hub’ to speed up research Seven research centres to be rolled out across UK
-
Roche presents new data in NMOSD, could challenge Alexion's SolirisReduced risk of relapse by 55%
-
J&J’s ponesimiod tops Aubagio in head-to-head MS trialSets up regulatory filings and possible approval next year
-
Gracell reports impressive data with one-day CAR-T for leukaemiaTakes fight to Novartis and Gilead
-
Merck takes evobrutinib for MS into phase 3, on mixed dataFirst drug in class to reach this stage for the illness
-
Can AZ’s Imfinzi challenge Tecentriq in small cell lung cancer?New data shows improvement in overall survival
-
F-star hires ex-BMS immuno-oncology leader
New CMO to oversee development of lead candidate
-
Lilly appoints Maura Dickler as VP of late phase oncology developmentShe will join the pharma firm from the Memorial Sloan Kettering Cancer Center
-
Metrion Biosciences establishes scientific advisory board
The board will provide scientific oversight and strategic advice to Metrion
-
Dr Sotirios Stergiopoulos leaves Shire for IpsenHe becomes the French biopharma’s chief medical officer
-
Linda Law joins Advicenne as US VP, clinical development and med affairsShe will oversee the biopharma’s developments with its dTRA candidate
Latest research appointments
Featured jobs
-
Account Director – UK Office
-
Excellent salary and benefits
-
Events Executive
-
DOE
- Account Manager – Healthcare advertising
-
Salary TBC
-
Senior Medical Writer
-
Competitive salary plus benefits
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
- Client Services Director- Flexible Working
-
Negotiable
Subscribe to our email news alerts
- Novartis eyes potential new indication for Cosentyx
- J&J's Tremfya filed for approval in US for psoriatic arthritis
- Envision Pharma Group relocates to support expansion
- Biogen loses another pipeline drug to toxicity concerns
- AZ, Merck’s Lynparza scores market-expanding clinical success
- Half of European cancer drug trials ‘biased’, says BMJ
PMHub
Health Unlimited
Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...
Latest intelligence
- Report: Customer experience, shaping digital healthcare
- In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
- Encouraging signs in biomarker R&D
- The cancer immunotherapy firms ramping-up biomarker R&D...
- Programmatic methodology and why you should be using it
- What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...
Quick links
Infographics
